[1]董永丽,史海霞,王 敏,等.基于网络药理学的葛根芩连汤治疗腹泻作用机制研究[J].陕西中医,2021,(5):659-664.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.029]
　DONG Yongli,SHI Haixia,WANG Min,et al.Mechanism of Gegen Qinlian decoction on diarrhea based on network pharmacology[J].,2021,(5):659-664.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.029]
点击复制

基于网络药理学的葛根芩连汤治疗腹泻作用机制研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年5期
页码:
659-664
栏目:
方药纵横
出版日期:
2021-05-05

文章信息/Info

Title:
Mechanism of Gegen Qinlian decoction on diarrhea based on network pharmacology
作者:
董永丽1; 史海霞1; 王 敏1; 刘全喜2
(1.中国中医科学院望京医院,北京 101002; 2.北京市中西医结合医院,北京 100039)
Author(s):
DONG Yongli; SHI Haixia; WANG Min; LIU Quanxi
(Wangjing Hospital of China Academy of Chinese Medical Sciences,Beijing 100102,China)
关键词:
腹泻;  葛根芩连汤;  网络药理学;  作用机制;  基因靶点
Keywords:
Diarrhea;  Gegen Qinlian decoction;  Network pharmacology;  Mechanism of action;  Gene targets
分类号:
R 285
DOI:
DOI:10.3969/j.issn.1000-7369.2020.05.029
文献标志码:
A
摘要:
目的:以网络药理学为载体探索葛根芩连汤治疗腹泻的基因靶点及作用通路。方法:初步检索中药系统药理学数据库与分析平台,查找目标中药的有效成分和基因靶点,定义生物利用度≥30%,类药性≥0.18,确定药物的作用靶点; 然后查询OMIM、DisGeNET、GeneCards数据库,挖掘腹泻疾病的潜在靶点。最后对两种基因取交集,构建中药—成分—靶基因—疾病的中药调控网络,对网络里面的基因构建蛋白互作网络,找到核心基因,进行基因本体和京都基因与基因组百科全书分析。结果: 最终确定葛根芩连汤中有效成分总共486个,去除重复后获得有效成分121个,基因靶点221个; 腹泻的疾病靶点5217个,二者共同靶点基因182个,PPI网络蛋白分析发现AKT1、CASP3、JUN、PTGS2、RELA、ESR1是葛根芩连汤治疗腹泻的核心靶点。基因本体分析确定了157个条目(P<0.05),其中生物过程主要通过DNA、RNA的转录,细胞因子的结合,蛋白酶的激活及细胞的代谢等过程发挥作用; 京都基因与基因组百科全书通路富集分析明确了167条信号通路,其中信号通路涉及炎症、细胞代谢、细胞衰老等方面,主要IL-17信号通路、TNF信号通路、HIF-1信号通路等。结论: 葛根芩连汤对腹泻的治疗主要通过抗炎、缓解肌肉痉挛等机制发挥作用; 其具体分子机制尚未得到验证,后期需要借助分子生物学研究,完善葛根芩连汤的作用机制,为临床用药提供新依据。
Abstract:
Objective:Use network pharmacology as a carrier to explore the gene targets and pathways of Gegen Qinlian decoction in the treatment of diarrhea.Methods:Preliminarily search the Chinese medicine system pharmacology database and analysis platform,find the effective ingredients and gene targets of the target Chinese medicine,define the bioavailability≥30%,the drug-like property≥0.18,and determine the target of the drug; then,query OMIM,DisGeNET,GeneCards database,mining potential targets of diarrhea diseases.Finally,take the intersection of the two genes to construct a traditional Chinese medicine-component-target gene-disease regulatory network,construct a protein interaction network for the genes in the network,find the core genes,and analyze the gene ontology and the Kyoto Encyclopedia of Genes and Genomes.Results:The results finally determined that there are a total of 486 active ingredients in Gegen Qinlian decoction,121 active ingredients and 221 gene targets are obtained after removing duplication; 5217 disease targets for diarrhea,182 common target genes for the two,PPI network protein analysis.It is found that AKT1,CASP3,JUN,PTGS2,RELA,ESR1 are the core targets of Gegen Qinlian decoction in the treatment of diarrhea.Gene ontology analysis identified 157 items(P<0.05).Among them,biological processes mainly play a role in the transcription of DNA and RNA,the binding of cytokines,the activation of proteases and the metabolism of cells; the Kyoto Encyclopedia of Genes and Genomes pathways are rich Collective analysis identified 167 signal pathways,of which the signal pathways involve inflammation,cell metabolism,cell aging,etc.The main IL-17 signal pathway,TNF signal pathway,and HIF-1 signal pathway.Conclusion:Gegen Qinlian decoction has the advantages of multiple targets and multiple pathways.The treatment of diarrhea is mainly through anti-inflammatory and relieving muscle spasm.The specific molecular mechanism of Gegen Qinlian decoction has not been verified,and it needs to be used in the later stage.Molecular biology research has perfected the mechanism of Gegen Qinlian decoction and provided a new basis for clinical medication.

参考文献/References:

[1] Carrasco LA,Lytvyn L,Falck YY,et al.AGA technical review on the evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults(IBS-D)[J].Gastroenterology,2019,157(3):859-880.
[2] Farthing M,Salam MA,Lindberg G,et al.Acute diarrhea in adults and children:A global perspective[J].J Clin Gastroenterol,2013,47(1):12-20.
[3] 陈 影,李 硕,苏 萍,等.中药抗腹泻的药效作用及机制研究进展[J].中国实验方剂学杂志,2019,25(21):203-211.
[4] 万凌峰.中医药治疗腹泻型肠易激综合征的临床研究进展[J].中国中医急症,2020,29(1):171-173.
[5] 曾恩锦,吕 林,王凤云,等.从“湿胜则濡泄”探讨功能性腹泻的中医治疗[J].中国中西医结合消化杂志,2020,28(2):96-98,103.
[6] 黄汝芹,郑 瑾,张兰会,等.葛根芩连汤加减治疗放射性肠炎急性期的分析及体会[J].中国中医急症,2017,26(8):1500-1501,1504.
[7] 卫 丽,白涛敏,高 颖,等.婴幼儿轮状病毒肠炎60例肠道外损害分析[J].陕西医学杂志,2017,46(9):1174-1175,1192.
[8] 方一珺,杭金玉.葛根芩连汤加减治疗小儿病毒性肠炎的临床观察[J].中西医结合研究,2020,12(2):112-113,121.
[9] 冯益静,夏陈伟,郑永红.葛根芩连汤治疗轮状病毒肠炎疗效观察[J].世界最新医学信息文摘,2019,19(86):117.
[10] 王国庆.葛根芩连汤治疗急性肠炎的临床疗效分析[J].中医临床研究,2017,9(10):101-102.
[11] 张 勇,翁素晶.葛根芩连汤治疗急性肠炎临床观察[J].亚太传统医药,2017,13(9):124-125.
[12] Fan Y,Yi W,Huang H,et al.Efficacy of herbal medicine(Gegen Qinlian decoction)on ulcerative colitis:A systematic review of randomized controlled trials[J].Medicine(Baltimore),2019,98(52):18512.
[13] 乔 峰,强文娟,高 东,等.葛根芩连汤配合针刺治疗溃疡性结肠炎活动期大肠湿热证临床研究[J].陕西中医,2019,40(11):1516-1519.
[14] 施晓伟,刘 文,王 群,等.葛根芩连汤的研究进展[J].贵阳中医学院学报,2013,34(1):21-24.
[15] 王华富,商振球,桂志红,等.中药黄连对临床常见耐药菌株的体外抑菌活性分析[J].中国药师,2018,21(9):1662-1664.
[16] 樵星芳,艾必燕,陈建康,等.8-辛基小檗碱盐酸盐的抑菌作用[J].医学动物防制,2010,26(1):54-55.
[17] 孙冬梅,邝枣园,李 岩,等.黄芩苷对耐药性金黄色葡萄球菌的抑菌作用研究[J].吉林医学,2011,32(13):2587-2588.
[18] 孙 琦,汤仁仙,范兴丽,等.葛根素对炎症反应综合征大鼠的治疗作用[J].中华急诊医学杂志,2008,17(2):158-161.
[19] 赵红艳,张 璠,范书铎,等.黄芩甙对发热大鼠下丘脑PGE2和cAMP含量的影响[J].中国应用生理学杂志,2002,18(2):139-141.
[20] 何 飞,刘 元,韦焕英,等.葛根芩连微丸止泻止痢药效学实验研究[J].中国实验方剂学杂志,2003,9(5):48-50.
[21] 于昌海,吴 微.中西医结合治疗腹泻型肠易激综合征的疗效分析[J].临床医药文献电子杂志,2020,7(27):62-63.
[22] 刘宇政,章 军,王跃生,等.葛根芩连汤剂量相关问题探讨[J].中国实验方剂学杂志,2010,16(16):216-218.
[23] 文颖娟.葛根芩连汤探析[J].陕西中医学院学报,2011,34(4):81-83.
[24] 李 梢,张 博.中药网络药理学:理论,方法与应用[J].中国天然药物,2013,11(2):110-120.
[25] Luo TT,Lu Y,Yan SK,et al.Network pharmacology in research of Chinese medicine formula:Methodology,application and prospective[J].Chin J Integr Med,2020,26(1):72-80.
[26] 王 辉,董 彬,苌沛森,等.葛根药性与功用考证[J].中医药导报,2016,23(19):75-77.
[27] 李远辉,刘佃飞,杨永福.葛根提取物的化学成分及其临床应用研究综述[J].中药与临床,2015,6(4):47-48.
[28] 黄 玲.黄连化学成分及有效成分药理活性的研究进展[J].中西医结合心血管病电子杂志,2020,8(17):136-137.
[29] 董 娟,徐 杰,王新国,等.葛根对细菌性腹泻模型小鼠淋巴细胞水平和胃肠传输功能的影响研究[J].陕西中医,2020,41(8):1047-1050.
[30] Luo XX,Zhu SL,Li BT,et al.Gegen Qinlian decoction activates PPARγ to ameliorate adipocytic insulin resistance in diabetic SD rats and IR-3T3-L1 adipocytes[J].China Journal of Chinese Materia Medica,2017,42(23):4641-4648.
[31] 杨 欣,李亚辉,钱海兵.中药葛根化学成分-靶标蛋白-通路-疾病关联性分析[J].中医药导报,2019,25(2):76-82.
[32] Kono M,Sakurai T,Okamoto K,et al.Usefulness of ustekinumab for treating a case of myelodysplastic syndrome-associated inflammatory bowel disease[J].Intern Med,2019,58(14):2029-2033.
[33] 何惠强.经方葛根芩连汤对急性肠胃炎患者血清IL-8、TNF-α、PCT水平的影响[J].现代医学与健康研究电子杂志,2020,4(5):68-69.
[34] Fabia DL,Butkevych E,Nattramilarasu PK,et al.Curcumin mitigates immune-induced epithelial barrier dysfunction by campylobacter jejuni[J].Int J Mol Sci,2019,20(19):4830.

相似文献/References:

[1]江 晟,陆 敏 .肠康方治疗腹泻型肠易激综合征临床研究*[J].陕西中医,2019,(3):331.
　JIANG Sheng,LU Min..Clinical observation of Changkang prescription in treating predominant irritable bowel syndrome[J].,2019,(5):331.
[2]邹卓琳,葛惠男△,周家程.葛惠男教授运用流气化湿法治疗慢性腹泻经验*[J].陕西中医,2019,(3):381.
[3]李淑华.黄芪建中汤加减联合双歧杆菌三联活菌乳杆菌片治疗小儿腹泻疗效及对患儿不良反应的影响*[J].陕西中医,2019,(7):851.
[4]邹 维,毛靓瑶△,刘 敏,等.温针灸治疗脾胃虚弱证腹泻型肠易激综合征临床研究[J].陕西中医,2019,(12):1786.
[5]郭利平.葛根芩连汤治疗湿热型2型糖尿病述评[J].陕西中医,2022,(2):139.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.001]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81503439); 中国中医科学院望京医院科研课题(WJYY2016-PY-033)
更新日期/Last Update: 2021-05-10